Open access
Open access
Powered by Google Translator Translator

Oncology (All Articles)

#ASCO2017 – Risk-Based Approach to Chemotherapy Duration Recommended for Stage III Colon Cancer

7 Jun, 2017 | 15:24h | UTC

#ASCO2017 (Unpublished results) – Risk-Based Approach to Chemotherapy Duration Recommended for Stage III Colon Cancer – ASCO Daily News(free) AND ASCO2017:The IDEA Collaboration: Global Study Sets New Risk-Based Standard to Personalize Chemotherapy for Colon Cancer After Surgery – ASCO Post (free)

Commentaries: Chemo Cut in Half Following Surgery Without Increased Recurrence Risk in Patients With Low-Risk Colon Cancer – Targeted Oncology (free) Less Is More: Patients With Colon Cancer Get a Chemo Break – Medscape (free registration required) Cutting Chemo Time in Low-Risk Colon Ca an Option – MedPage Today (free registration required)

 


#ASCO2017 – Biosimilar May Be As Effective as Trastuzumab for Early Breast Cancer

7 Jun, 2017 | 15:13h | UTC

#ASCO2017 – CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial – The Lancet Oncology (link to abstract – $ for full-text)

Commentary: Biosimilar May Be As Effective as Trastuzumab for Early Breast Cancer – Physician’s First Watch (free)

 


#ASCO2017 – Small studies get big headlines

7 Jun, 2017 | 15:12h | UTC

#ASCO2017 – Small studies get big headlines at ASCO 2017 – HealthNewsReview (free)

“Claim – Biggest breakthrough in a decade”. “Reality – The trial included only 15 women; no survival outcomes measured” (RT @HealthNewsRevu see Tweet)

 


#ASCO2017 – Survival in a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Cancer Treatment

5 Jun, 2017 | 14:52h | UTC

#ASCO2017 – Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment – JAMA (free)

Commentaries: Quickly reporting cancer complications may boost survival – STAT News (free) AND If This Were a Drug, the Price Would Be $100,000 – Medscape (free registration required) AND How a simple tech tool can help cancer patients live longer – The Washington Post (free)

“For surveillance of cancer, digital tracking of patient-generated data improves survival”. “The cost of digital tracking is very low and > 5 months median survival improvement is more than cancer drugs that cost > $100,000” (RT @EricTopol see Tweets and Answers)

 


#ASCO2017 – Abiraterone for Prostate Cancer

5 Jun, 2017 | 14:51h | UTC

#ASCO2017 – Abiraterone for Prostate Cancer

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer – New England Journal of Medicine (free) AND Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy – New England Journal of Medicine (free)

ASCO News Releases: Abiraterone Delays Metastatic Prostate Cancer Growth by 18 Months, Extends Survival (free) Abiraterone Slows Advanced Prostate Cancer, Helps Patients Live Longer (free)

 


Association of a Bundled-Payment Program With Cost and Outcomes in Full-Cycle Breast Cancer Care

4 Jun, 2017 | 19:16h | UTC

Association of a Bundled-Payment Program With Cost and Outcomes in Full-Cycle Breast Cancer Care – JAMA Oncology (link to abstract – $ for full-text)

Commentary: ‘Bundled’ Payments Beat Fee-for-Service: Cost, quality of care, and survival rates all better – MedPage Today (free registration required)

Related: Value-Based Care in the Worldwide Battle Against Cancer – Cureus (free)

 


Recent Advances in Bronchoscopic Treatment of Peripheral Lung Cancers

4 Jun, 2017 | 19:10h | UTC

Review: Recent Advances in Bronchoscopic Treatment of Peripheral Lung Cancers – Chest (free)

 


Changing Trends and Practices in Cytopathology

4 Jun, 2017 | 19:09h | UTC

Changing Trends and Practices in Cytopathology – Acta Cytologica (free)

 


Cancer drugs are getting better and dearer

1 Jun, 2017 | 18:27h | UTC

Cancer drugs are getting better and dearer – The Economist (a few articles per month are free) (RT @pash22 see Tweet)

See more articles and commentaries about “financial toxicity” of cancer treatments in our April 27 issue, see #8.

 


Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk

30 May, 2017 | 15:27h | UTC

Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: meta-analysis of individual participant data of seven prospective cohorts in Europe – British Journal of Cancer (free)

Commentaries: Why your waist measurement can predict cancer risk – The Guardian (free) AND Large Waist Raises Cancer Risk – Medscape (free registration required)

 


Exercise and other non-pharmaceutical interventions for cancer-related fatigue in patients during or after cancer treatment

29 May, 2017 | 15:21h | UTC

Exercise and other non-pharmaceutical interventions for cancer-related fatigue in patients during or after cancer treatment: a systematic review incorporating an indirect-comparisons meta-analysis – British Journal of Sports Medicine (free)

Commentary: Several non-drug options help with fatigue during, after cancer treatment – Reuters Health News (free)

 


Cancer Pain – Updated PDQ Cancer Information Summary

29 May, 2017 | 15:17h | UTC

Cancer Pain – Updated PDQ Cancer Information Summary, National Cancer Institute (US) (free)

 


Thrombocytosis and cancer

29 May, 2017 | 15:18h | UTC

Clinical relevance of thrombocytosis in primary care: a prospective cohort study of cancer incidence using English electronic medical records and cancer registry data – British Journal of General Practice (link to abstract – $ for full-text)

Commentaries: Cautions and caveats help buoy Guardian story on using high platelet count for cancer detection – HealthNewsReview (free) High blood platelet count ‘as good a cancer predictor as a lump in the breast’ – The Guardian (free)

Thrombocytosis seems to be a risk marker of cancer in adults, but questions remain about the clinical usefulness of these findings.

 


Reducing Risk After Cancer: Healthy Lifestyle (and Tree Nuts)

26 May, 2017 | 15:06h | UTC

American Society of Clinical Oncology (ASCO) 2017 Annual Meeting

Can cashews keep colon cancer patients alive? Study says yes — but cautions abound – STAT News (free) AND Reducing Risk After Cancer: Healthy Lifestyle (and Tree Nuts) – Medscape (free registration required)

 


Multiple Myeloma Guidelines

24 May, 2017 | 14:41h | UTC

Guidelines for screening and management of late and long-term consequences of myeloma and its treatment – British Journal of Haematology(free)

Related: Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up – Annals of Oncology (free)

 


Just one alcoholic drink a day may increase breast cancer risk

24 May, 2017 | 14:39h | UTC

Diet, Nutrition, Physical Activity and Breast Cancer – American Institute for Cancer Research (free PDF)

News release: Just one alcoholic drink a day increases breast cancer risk, exercise lowers risk – American Institute for Cancer Research, via EurekAlert (free)

Commentaries: Today’s alcohol and breast cancer headlines are wrong: Here’s how news reports could have done better – HealthNewsReview(free) AND ‘Half a glass of wine every day’ increases breast cancer risk – BBC Health News (free) AND Just One Drink a Day Raises Breast Cancer Risk – Medscape (free registration required)

 


Cancer screening in the United States, 2017

23 May, 2017 | 14:27h | UTC

Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening – CA: A Cancer Journal for Clinicians (free)

 


Hepatobiliary Cancers – NCCN Guidelines Insights

12 May, 2017 | 19:32h | UTC

NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017 (free)

 


Hodgkin Lymphoma – NCCN Clinical Practice Guidelines

12 May, 2017 | 19:31h | UTC

Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology (free)

 


Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline

11 May, 2017 | 18:35h | UTC

Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline (free)

Source: Urologic Groups Offer New Prostate Cancer Management Guideline – Physician’s First Watch (free)

 


Screening for Thyroid Cancer: USPSTF Recommendation Statement

10 May, 2017 | 18:29h | UTC

Screening for Thyroid Cancer: US Preventive Services Task Force Recommendation Statement – JAMA (free)

Editorial 1: The USPSTF Recommendation on Thyroid Cancer Screening: Don’t “Check Your Neck” (free)

Editorial 2: Cancer Screening, Overdiagnosis, and Regulatory Capture (free)

Editorial 3: How to Look for Thyroid Cancer (free)

Commentaries: No Symptoms, No Thyroid Screening, Says USPSTF – Medscape (free registration required) AND Don’t Screen For Thyroid Cancer, Task Force Says – NPR Health News (free) AND USPSTF Says No to Thyroid Cancer Screening – MedPage Today (free registration required)

The USPSTF recommended against screening for thyroid cancer in asymptomatic adults with “grade D” recommendation (Grade D = “The USPSTF recommends against the service. There is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits”).

 


Guidelines for the management of gastrointestinal stromal tumours (GIST)

10 May, 2017 | 18:25h | UTC

UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST) – Clinical Sarcoma Research (free)

 


Guideline for the Management of Fever and Neutropenia in Children

10 May, 2017 | 18:24h | UTC

Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update (free)

 


Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images

6 May, 2017 | 20:34h | UTC

Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017 – Radiology (free)

Source: Management of Pulmonary Nodules Found Incidentally on Computed Tomography Scans – Journal Watch (free)

Incidental pulmonary nodules discovered outside the context of screening or cancer follow-up are increasingly common in clinical practice. The purpose of these updated recommendations is to reduce the number of unnecessary follow-up examinations while providing practical guidance on follow-up intervals for selected larger nodules.

 


ASCO Guideline on Castrate-Resistant Prostate Cancer

3 May, 2017 | 17:23h | UTC

Second-Line Hormonal Therapy for Men With Chemotherapy-Naïve, Castration-Resistant Prostate Cancer: American Society of Clinical Oncology Provisional Clinical Opinion (free)

Source: ASCO Issues Guideline on Castrate-Resistant Prostate Cancer – Medscape (free registration required)

 


Stay Updated in Your Specialty

No spam, just news.